Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
Login Archives Your Team About Us FAQ
[mmpazkzone name="azk58712-mobile-nav" network="9794" site="307044" id="222451" type="5"]
  • Subscribe
Enter stock ticker or keyword
×
[mmpazkzone name="azk58712-mobile-sticky" network="9794" site="307044" id="222451" type="5"]
Join 100,000+ Like-Minded Investors Today
Twitter
Tags: IPOs
Stocks: AKCA, NETS, OBSV, VERI

New IPO Movers of the Week

By Stephen Mack, Associate Editor, Money Morning • August 28, 2017

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

New IPO Movers

Our top loser from last week's new IPO* movers is back in the cellar. Otherwise, it's all new faces.

Veritone Inc. (Nasdaq: VERI) soared head and shoulders above the rest of the pack, gaining 75.6%. The stock shot up early last Monday after a feature by Barron's on Aug. 18 said Veritone was leading the way in the development of artificial intelligence. VERI continued to rise over the rest of the week, though the share price did begin to pull back on Friday. The stock closed the week at $13.77, still shy of its May IPO price of $15.

Akcea Therapeutics Inc. (Nasdaq: AKCA) first topped our winners list for the week of July 17-21, jumping 42.7% immediately after the closing of its IPO. Last week, the drug company registered another big gain of 30.4%. Shares closed the week at $18.41, well over double its IPO price of $8. It's surprising to see the stock so high after Akcea had to slash its IPO price from earlier expectations of $12 to $14. But as we've always said, these IPO stocks are often volatile.

BREAKING: New Legislation Could Turn Tiny Pot Stocks into Millions. Click Here...

Online retailer Netshoes Ltd. (NYSE: NETS) led our losers list last week after dropping 20.6% the week before. That came after beating earnings expectations for the last quarter. But the company is still losing money and missed revenue estimates. The stock has been steadily declining ever since, falling 17.1% last week after closing all five days lower than the last. The Brazilian company's April IPO was priced at $18. Shares climbed to over $26 in May, but have been on the decline since then. NETS closed the week at $12.18.

ObsEva SA (Nasdaq: OBSV) made four consecutive appearances on our new IPO movers list in June, falling for two weeks, then recovering over the next two. The Swiss pharmaceutical company, specializing in women's fertility treatments, didn't move much immediately after releasing its earnings report on Aug. 15. Perhaps the 14.6% drop last week was a delayed reaction, as the company reported -$0.61 earnings per share (EPS), substantially worse than the expected -$.0.45 EPS. Shares closed the week at $6.56, less than half of its January IPO price of $15.

*Stocks are listed on a U.S. exchange with an initial public offering in the last year. Data and analytics provided by FactSet.

Up Next: One gallon of this new "crystal fuel" could get you from New York to L.A. and back... seven times! Being hailed by many experts as energy's "Holy Grail," it's 1,693 times more powerful than the gasoline that runs your car. The mainstream investment media isn't even talking about it yet. Read more...

Follow Money Morning on Twitter @moneymorning, Facebook, and LinkedIn.

[mmpazkzone name="end-story-hostage" network="9794" site="307044" id="138536" type="4"]

Stephen MackStephen Mack

About the Author

Browse Stephen's articles |

Stephen Mack has been writing about economics and finance since 2011. He contributed material for the best-selling books Aftershock and The Aftershock Investor. He lives in Baltimore, Maryland.

… Read full bio

ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us How Money Morning Works FAQs Contact Us Search Article Archive Your Team Text Messaging Terms of Use
TOPICS
AI Investing Best Stocks to Buy Stock Forecasts Stocks to Sell Now Technology Stocks Best REITs to Buy Now IPO Stocks Penny Stocks Dividend Stocks Cryptocurrencies How to Trade Options Best Trades to Make Now Options Trading Strategies Weekly Trade Recommendations Income Investing Guide Retirement Articles Special Investing Reports Meet Our Experts
PREMIUM SERVICES
Money Map Press Home Fast Fortune Club Microcurrency Trader Rocket Wealth Initiative Quantum Data Profits Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information